Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease Project

Not Applicable

Recruiting

• Conditions: Medication compliance and persistence; Cardiovascular - Hypertension; Public Health - Health service research

• Registration Number: ACTRN12609000705280
• Lead Sponsor: Monash

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 450

Inclusion Criteria

Using or have used one or more antihypertensive medications (angiotensin converting enzyme inhibitors, angiotensin-II receptor antagonists, calcium channel blockers, beta blockers and thiazide diuretics) in the last 6 months, primary hypertension confirmed by the GP, and
available for follow-up at 6 months.

Exclusion Criteria

Participation in other compliance promotion or medication profiling programs or receipt of a recent home medicines review, unavailable for follow-up, unable to
communicate in English, and does not self-
administer anti-hypertensive medicines.

Study & Design

• Study Type: Interventional
• Study Design: Not specified